Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002976172 | SCV003288989 | uncertain significance | Fanconi anemia | 2022-05-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This variant is present in population databases (rs771248011, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 1866 of the FANCM protein (p.Arg1866Ser). |
Ambry Genetics | RCV004973790 | SCV005586980 | uncertain significance | Inborn genetic diseases | 2024-12-01 | criteria provided, single submitter | clinical testing | The p.R1866S variant (also known as c.5598G>T), located in coding exon 21 of the FANCM gene, results from a G to T substitution at nucleotide position 5598. The arginine at codon 1866 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |